For founders

We value founders with ambition, intellectual honesty, and the discipline to build through complexity. We are particularly drawn to leaders who understand that in healthcare and life sciences, enduring companies are rarely built through momentum alone. They are built through strategic clarity, operational rigor, and the ability to translate innovation into real adoption.

Our aim is to be a thoughtful partner to teams building in consequential markets, especially where the path to scale requires more than conventional pattern matching.

What We Back

We focus on early growth-stage healthcare and life sciences companies operating in areas such as diagnostics, clinical workflow, women’s health, digital infrastructure, therapeutics, and other enabling technologies that improve outcomes, efficiency, or access.

We focus on early growth-stage healthcare and life sciences companies operating in areas such as diagnostics, clinical workflow, women’s health, digital infrastructure, therapeutics, and other enabling technologies that improve outcomes, efficiency, or access.

We focus on early growth-stage healthcare and life sciences companies operating in areas such as diagnostics, clinical workflow, women’s health, digital infrastructure, therapeutics, and other enabling technologies that improve outcomes, efficiency, or access.

Where We Engage

We typically engage once a company has moved beyond concept and is showing evidence of traction, whether through commercial adoption, validated clinical value, strong customer pull, or a clear path to scaled deployment.

We typically engage once a company has moved beyond concept and is showing evidence of traction, whether through commercial adoption, validated clinical value, strong customer pull, or a clear path to scaled deployment.

We typically engage once a company has moved beyond concept and is showing evidence of traction, whether through commercial adoption, validated clinical value, strong customer pull, or a clear path to scaled deployment.

Target initial check size: $500,000 to $1,500,000.

What We Look For

Demonstrated Traction

We look for evidence that the company is solving a real problem and is gaining meaningful market validation.

Demonstrated Traction

We look for evidence that the company is solving a real problem and is gaining meaningful market validation.

Demonstrated Traction

We look for evidence that the company is solving a real problem and is gaining meaningful market validation.

System Alignment

We favor solutions that fit the realities of reimbursement, clinical workflow, regulation, procurement, and healthcare economics.

System Alignment

We favor solutions that fit the realities of reimbursement, clinical workflow, regulation, procurement, and healthcare economics.

System Alignment

We favor solutions that fit the realities of reimbursement, clinical workflow, regulation, procurement, and healthcare economics.

Exceptional Teams

We back founders with deep domain understanding, strong execution capability, and the ability to build durable organizations.

Exceptional Teams

We back founders with deep domain understanding, strong execution capability, and the ability to build durable organizations.

Exceptional Teams

We back founders with deep domain understanding, strong execution capability, and the ability to build durable organizations.

Clear Path to Scale

We prioritize businesses with credible go-to-market plans, repeatable demand, and the potential for significant value creation.

Clear Path to Scale

We prioritize businesses with credible go-to-market plans, repeatable demand, and the potential for significant value creation.

Clear Path to Scale

We prioritize businesses with credible go-to-market plans, repeatable demand, and the potential for significant value creation.

How We Work with Founders

We aim to be high-value partners. That means thoughtful strategic input, practical healthcare market perspective, introductions where relevant, and a bias toward helping founders navigate complex operating environments without unnecessary friction.

We aim to be high-value partners. That means thoughtful strategic input, practical healthcare market perspective, introductions where relevant, and a bias toward helping founders navigate complex operating environments without unnecessary friction.

We aim to be high-value partners. That means thoughtful strategic input, practical healthcare market perspective, introductions where relevant, and a bias toward helping founders navigate complex operating environments without unnecessary friction.

What to Send

A concise overview is best: what the company does, the problem being solved, current traction, the financing round, and why Totipotent may be a strong fit.

A concise overview is best: what the company does, the problem being solved, current traction, the financing round, and why Totipotent may be a strong fit.

A concise overview is best: what the company does, the problem being solved, current traction, the financing round, and why Totipotent may be a strong fit.

What kinds of companies do you invest in?

We invest in healthcare and life sciences companies where clinical relevance, operational value, and system-level alignment create the potential for durable growth.

What stage do you invest at?

We usually invest after the earliest stage of company formation, when there is evidence of traction, product-market fit, customer validation, or another meaningful de-risking milestone.

What size checks do you write?

Our target initial check size is generally $500,000 to $1,500,000, depending on the company, round structure, and fit.

What matters most in your evaluation process?

We care most about the magnitude of the problem, evidence of traction, quality of the team, healthcare system fit, and the credibility of the scaling plan.

Do you only back software companies?

No. We invest across healthcare and life sciences, including software, diagnostics, devices, therapeutic platforms, and other enabling technologies.

How involved are you after investing?

We aim to be engaged and useful, especially where our healthcare market knowledge, operating experience, and network can help the company progress more effectively.

What should I send first?

A short deck or concise summary is sufficient to start, as long as it clearly explains the company, traction, round, and why the fit with Totipotent makes sense.

How do I get in touch?

Use the contact form or reach out at info@totipotent.vc.

Why Totipotent, now

Healthcare and life sciences are entering a period defined by scientific acceleration, structural strain, shifting consumer behavior, and a rising premium on efficiency, relevance, and execution. In that environment, the most enduring companies will not simply tell compelling stories. They will solve important problems in ways that hold up under real-world conditions. Totipotent exists to identify and support those companies.

Healthcare and life sciences are entering a period defined by scientific acceleration, structural strain, shifting consumer behavior, and a rising premium on efficiency, relevance, and execution. In that environment, the most enduring companies will not simply tell compelling stories. They will solve important problems in ways that hold up under real-world conditions. Totipotent exists to identify and support those companies.

Healthcare and life sciences are entering a period defined by scientific acceleration, structural strain, shifting consumer behavior, and a rising premium on efficiency, relevance, and execution. In that environment, the most enduring companies will not simply tell compelling stories. They will solve important problems in ways that hold up under real-world conditions. Totipotent exists to identify and support those companies.

Why Totipotent, now

Healthcare and life sciences are entering a period defined by scientific acceleration, structural strain, shifting consumer behavior, and a rising premium on efficiency, relevance, and execution. In that environment, the most enduring companies will not simply tell compelling stories. They will solve important problems in ways that hold up under real-world conditions. Totipotent exists to identify and support those companies.